ABMC — American Bio Medica Cashflow Statement
0.000.00%
Last trade - 00:00- $0.01m
- $0.12m
- $0.91m
Annual cashflow statement for American Bio Medica, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2018 December 31st | 2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -1.03 | -0.681 | -0.796 | -0.463 | -1.41 |
| Depreciation | |||||
| Non-Cash Items | 0.26 | 0.225 | 0.251 | -0.497 | 0.154 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | 0.467 | 0.433 | -0.017 | 0.219 | 0.437 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Prepaid Expenses | |||||
| Change in Other Assets | |||||
| Change in Accounts Payable | |||||
| Change in Accrued Expenses | |||||
| Change in Other Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | -0.22 | 0.058 | -0.483 | -0.673 | -0.768 |
| Capital Expenditures | -0.022 | 0 | -0.004 | 0 | — |
| Purchase of Fixed Assets | |||||
| Purchase / Acquisition of Intangibles | |||||
| Cash from Investing Activities | -0.022 | 0 | -0.004 | 0 | — |
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 0.319 | -0.167 | 0.581 | 0.69 | 0.687 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 0.077 | -0.109 | 0.094 | 0.017 | -0.081 |